Found: 9
Select item for more details and to access through your institution.
Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 65, doi. 10.1111/j.1755-5949.2008.00065.x
- By:
- Publication type:
- Article
Pharmacology of Ramelteon, a Selective MT<sub>1</sub>/MT<sub>2</sub> Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 32, doi. 10.1111/j.1755-5949.2008.00066.x
- By:
- Publication type:
- Article
Distinct Brain Volume Changes Correlating with Clinical Stage, Disease Progression Rate, Mutation Size, and Age at Onset Prediction as Early Biomarkers of Brain Atrophy in Huntington's Disease.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 1, doi. 10.1111/j.1755-5949.2008.00068.x
- By:
- Publication type:
- Article
Beta-2 Receptor Antagonists for Traumatic Brain Injury: A Systematic Review of Controlled Trials in Animal Models.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 52, doi. 10.1111/j.1755-5949.2008.00069.x
- By:
- Publication type:
- Article
The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD).
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 84, doi. 10.1111/j.1755-5949.2008.00071.x
- By:
- Publication type:
- Article
Low Risk of Development of Substance Dependence for Barbiturates and Clobazam Prescribed as Antiepileptic Drugs: Results from a Questionnaire Study.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 24, doi. 10.1111/j.1755-5949.2008.00073.x
- By:
- Publication type:
- Article
Comparative Neuroprotective Properties of Stilbene and Catechin Analogs: Action Via a Plasma Membrane Receptor Site?
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 76, doi. 10.1111/j.1755-5949.2008.00074.x
- By:
- Publication type:
- Article
Clinical Evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): A New Instrument to Assess the Onset of Symptomatic Improvement in Generalized Anxiety Disorder.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 12, doi. 10.1111/j.1755-5949.2008.00075.x
- By:
- Publication type:
- Article
Open-Label Support for Duloxetine for the Treatment of Panic Disorder.
- Published in:
- CNS Neuroscience & Therapeutics, 2009, v. 15, n. 1, p. 19, doi. 10.1111/j.1755-5949.2008.00076.x
- By:
- Publication type:
- Article